Patents Assigned to Affinity Biotech, Inc.
  • Patent number: 5320848
    Abstract: A non-aqueous, chewable composition for oral delivery of unpalatable drugs is provided. The composition contains the drug intimately dispersed or dissolved in a pharmaceutically-acceptable lipid that is solid at room temperatures. The composition also has a matrix that contains a granulating agent for the total composition and a rapid dispersal agent and optionally additives such as buffering agents, flavoring agents, surfactants, and the like. Methods for the preparation of the chewable compositions are also provided.
    Type: Grant
    Filed: May 27, 1992
    Date of Patent: June 14, 1994
    Assignee: Affinity Biotech, Inc.
    Inventors: Robert P. Geyer, Vinod V. Tuliani
  • Patent number: 5310960
    Abstract: A novel neomorphic form of ibuprofen and processes for its preparation are provided. The neomorphic ibuprofen is characterized by having a distinctively less bitter and acidic taste commonly associated with conventional ibuprofen and which causes less burning sensation upon swallowing. The neomorphic form of ibuprofen is an amorphous ibuprofen and is prepared by resolidifying supercooled ibuprofen at a process temperature below 0.degree. C.
    Type: Grant
    Filed: July 2, 1993
    Date of Patent: May 10, 1994
    Assignee: Affinity Biotech, Inc.
    Inventors: Robert P. Geyer, Vinod V. Tuliani
  • Patent number: 5310961
    Abstract: A novel neomorphic form of ibuprofen and processes for preparing the ibuprofen are provided. The neomorphic form is characterized by having a distinctively less bitter taste and causes less burning sensation upon swallowing. The neomorphic form of ibuprofen is an amorphous ibuprofen and is prepared by imparting kinetic energy to supercooled ibuprofen.
    Type: Grant
    Filed: July 2, 1993
    Date of Patent: May 10, 1994
    Assignee: Affinity Biotech, Inc.
    Inventors: Robert P. Geyer, Vinod V. Tuliani
  • Patent number: 5110606
    Abstract: Palatable liquid therapeutic microemulsion wherein a drug dissolved in propylene glycol is dispersed in fatty ester. Lecithin is the emulsifier.
    Type: Grant
    Filed: November 13, 1990
    Date of Patent: May 5, 1992
    Assignee: Affinity Biotech, Inc.
    Inventors: Robert P. Geyer, Vinod Tuliani
  • Patent number: 5073383
    Abstract: Aggregation of fluorocarbon emulsion particles, which occurs when the emulsion mixes with blood, is reduced by the addition of relatively large amounts of phosphate.
    Type: Grant
    Filed: April 21, 1989
    Date of Patent: December 17, 1991
    Assignee: Affinity Biotech, Inc.
    Inventor: Robert T. Lyons
  • Patent number: 4975528
    Abstract: Lipoproteins are separated from their aqueous solutions, e.g., blood, by treatment with PFC emulsified with phospholipid and then separating the emulsion containing the apolipoproteins. The latter are readily separated from the emulsion.
    Type: Grant
    Filed: October 16, 1989
    Date of Patent: December 4, 1990
    Assignee: Affinity Biotech, Inc.
    Inventors: Edward A. Kaminski, Albert J. Owen
  • Patent number: 4975468
    Abstract: A fluorocarbon microemulsion is provided which contains an ethoxylated alcohol as surfactant, the alcohol containing a tertiary carbon atom.
    Type: Grant
    Filed: April 3, 1989
    Date of Patent: December 4, 1990
    Assignee: Affinity Biotech, Inc.
    Inventor: Seang H. Yiv